Cite
HARVARD Citation
Agarwal, R. et al. (2018). Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials. Leukemia & lymphoma. 59 (12), pp. 2769-2781. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Agarwal, R. et al. (2018). Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials. Leukemia & lymphoma. 59 (12), pp. 2769-2781. [Online].